Proposal for a New Oncology Seminar for Fellows
Jeffrey E. Johnson, M.D.

Perioperative Considerations in Immune Checkpoint Inhibitor Therapy
Tina J. Hieken, M.D.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Describe the role that decision-making has in effecting patient outcomes
• Describe challenges and techniques in patient counseling and education
• Describe the mechanism of action and the role of immune checkpoint inhibitors (ICI) in the treatment of cancer
• Describe the immune-related adverse events that can occur with these therapies
• Describe the appropriate preop and postop management of patients undergoing surgery who have had ICI treatment

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenters:
Jeffrey E. Johnson, M.D. and Tina J. Hieken, M.D.

Support location:
Minnesota